Skip to content

Diagnostic Trial of Non-Contact Millimeter-Wave Radar-Based ECG Monitoring for Atrial Fibrillation

Diagnostic Trial of Non-Contact Millimeter-Wave Radar-Based ECG Monitoring for Atrial Fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108582
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-09
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Gold Standard:The standard 12-lead electrocardiogram (ECG) and 24-hour Holter monitoring serve as the gold standard for diagnosis. Atrial fibrillation can be diagnosed if characteristic ECG features a
Index test:The millimeter-wave radar-based non-contact ECG monitoring technology device

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 years or older, regardless of gender; 2.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Cardiogenic shock (systolic blood pressure < 90 mmHg, 1 mmHg=0.133 kPa); 2. Cardiac arrest; 3. Electrophysiological implantable devices (such as pacemakers, cardioverter defibrillators, etc.) due to severe arrhythmias; 4. Pregnant/lactating women; 5. Those who are critically ill or suffer from physical and mental illnesses and cannot cooperate with the experiment.

Design outcomes

Primary

MeasureTime frame
Diagnostic Results from the Millimeter-Wave Radar-Based Non-Contact ECG Monitoring Device;

Countries

China

Contacts

Public ContactWei Wang

The First Affiliated Hospital of Army Medical University

weiericwang@163.com+86 23 68765491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026